Fulgent Genetics, Inc. (FLGT) — 10-Q Filings

10-Q Filings (6)

• Fulgent Genetics Boosts Revenue 17% Amidst Strategic Shift — Nov 7, 2025 Risk: medium
  Fulgent Genetics, Inc. (FLGT) reported a significant increase in revenue for the three months ended September 30, 2025, reaching $84.069 million, up from $71.74
• Fulgent Genetics Navigates Post-COVID Revenue Dip — Aug 1, 2025 Risk: high
  Fulgent Genetics, Inc. (FLGT) reported a significant decline in revenue and net income for the second quarter ended June 30, 2025, primarily due to the decrease
• Fulgent Genetics Files Q1 2025 10-Q — May 2, 2025 Risk: low
  Fulgent Genetics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, previously known as Fulgent Diagnostics, Inc., is based in El Monte, Ca
• Fulgent Genetics Files Q3 2024 10-Q — Nov 8, 2024 Risk: medium
  Fulgent Genetics, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and operational updates.
• Fulgent Genetics Files Q2 2024 10-Q — Aug 2, 2024 Risk: medium
  Fulgent Genetics, Inc. filed its 10-Q for the period ending June 30, 2024. The company, headquartered in El Monte, CA, reported its financial status. Key financ
• Fulgent Genetics, Inc. Files 10-Q for Period Ending March 31, 2024 — May 3, 2024 Risk: medium
  Fulgent Genetics, Inc. (FLGT) filed a Quarterly Report (10-Q) with the SEC on May 3, 2024. Fulgent Genetics, Inc. filed a 10-Q report for the period ending Marc

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX